Vimarsana
Biggest News Aggregation in the World

Page 42 - Published May News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Published May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Published May Today - Breaking & Trending Today

Pacsun, Puma and Timberland to Share Connected Commerce Priorities at Retail Innovation Conference - Vimarsana News

Pacsun, Puma and Timberland to Share Connected Commerce Priorities at Retail Innovation Conference

Shop Eat Surf readers who want to learn about connected commerce trends can redeem a 50% discount to attend the Retail Innovation Conference.

ULM School of VAPA to host summer music camps June 7-10 - Vimarsana News

ULM School of VAPA to host summer music camps June 7-10

The University of Louisiana Monroe School of Visual and Performing Arts will host summer music camps for high school students, from June 7-10, 2023, on the ULM campus. These camps are designed for students to learn and grow as drum majors, percussionists, leaders, and musicians. Students will be instructed by ULM faculty and excellent guest instructors.

Source: ulm.edu
Huf Elevates Long-Time Employees After C-Suite Changes - Vimarsana News

Huf Elevates Long-Time Employees After C-Suite Changes

Huf named Keith Murray and Hanni El Khatib as chief operating officer and chief creative officer, respectively.

Why Hang Loose Favors Latin American Sourcing - Vimarsana News

Why Hang Loose Favors Latin American Sourcing

Hang Loose outlines why it favors sourcing in Latin America, including environmental and social benefits, and faster turnaround time.

FDA Committee Votes in Favor of Intranasal Epinephrine for Severe Allergic Reactions Including Anaphylaxis - Vimarsana News

FDA Committee Votes in Favor of Intranasal Epinephrine for Severe Allergic Reactions Including Anaphylaxis

It was announced by ARS Pharmaceuticals, Inc., that a US Food and Drug Administration Drug Advisory Committee voted in favor of a new intranasal epinephrine treatment for severe allergic reactions.